| Code | 7291E | ||||||||||
| MA number | 59/0208/24-S | ||||||||||
| Product Form: | tbl flm 168x30 mg (blis.OPA/Al/PVC//Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | KRKA, d.d., Novo mesto, Slovenia | ||||||||||
| Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | blister OPA/Al/PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 28.08.2024 |
| Validity: | 28.08.2029 |
| PIL: |
PIL_Apremilast Krka_08.2024.pdf
|
| SPC: |
SPC_Apremilast_Krka _08.2024.pdf
|
| Safety feature | Yes |
| Data update: | 09.09.2024 |
